News

MedPage Today on MSN2d
Kennedy's ACIP Backs Monoclonal Antibody for RSV Prevention in Infants
The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...
STAT2d
Pharmalittle: We’re reading about the gray market for obesity meds, an RSV drug recommendation, and more
Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...
RSV can cause severe disease for babies, this drug could prevent it
RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...
Vaccine for RSV shown to reduce the risk of dementia
A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...
RFK Jr.’s advisers back Merck’s RSV shot for newborns
Robert F. Kennedy Jr.’s vaccine advisory committee recommended Merck & Co.’s shot to prevent newborns from getting RSV, ...
Infectious Disease Advisor2d
RSV PreF IgG Antibodies Peak 1 Month After Infection, Wane at 6 Months
Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.
Fierce Biotech2d
Gilead blames low RSV infection rates last season for scrapping 2 obeldesivir trials
Gilead has blamed the low rate of respiratory syncytial virus (RSV) infections last season for ending two mid-stage trials of ...